VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (5919)	11/12/1998 9:09:00 AM
From: bluejeans	Read Replies (1) of 9719

Looks like someone's short may pay off fast. interactive.wsj.com Last February, EntreMed Inc., a tiny biotech company that licensed the two biological agents, hired Harvard cell biologist Bjorn Olsen to look into endostatin. Using endostatin variants he made, he couldn't reproduce Dr. Folkman's results, Dr. Olsen says.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next